• 1
    Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J. and DeMars, R., A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990 248: 220223.
  • 2
    Rouas-Freiss, N., Goncalves, R. M., Menier, C., Dausset, J. and Carosella, E. D., Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 1997 94: 1152011525.
  • 3
    Blaschitz, A., Lenfant, F., Mallet, V., Hartmann, M., Bensussan, A., Geraghty, D. E., Le Bouteiller, P. et al., Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur. J. Immunol. 1997 27: 33803388.
  • 4
    Crisa, L., McMaster, M. T., Ishii, J. K., Fisher, S. J. and Salomon, D. R., Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J. Exp. Med. 1997 186: 289298.
  • 5
    Ishitani, A. and Geraghty, D. E., Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA 1992 89: 39473951.
  • 6
    Kirszenbaum, M., Moreau, P., Gluckman, E., Dausset, J. and Carosella, E., An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. USA 1994 91: 42094213.
  • 7
    Fujii, T., Ishitani, A. and Geraghty, D. E., A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 1994 153: 55165524.
  • 8
    Paul, P., Cabestre, F. A., Ibrahim, E. C., Lefebvre, S., Khalil-Daher, I., Vazeux, G., Quiles, R. M. et al., Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum. Immunol. 2000 61: 11381149.
  • 9
    Park, G. M., Lee, S., Park, B., Kim, E., Shin, J., Cho, K. and Ahn, K., Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem. Biophys. Res. Commun. 2004 313: 606611.
  • 10
    Dong, Y., Lieskovska, J., Kedrin, D., Porcelli, S., Mandelboim, O. and Bushkin, Y., Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum. Immunol. 2003 64: 802810.
  • 11
    Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A. and Carosella, E. D., Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc. Natl. Acad. Sci. USA 2001 98: 1215012155.
  • 12
    Le Friec, G., Laupeze, B., Fardel, O., Sebti, Y., Pangault, C., Guilloux, V., Beauplet, A. et al., Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum. Immunol. 2003 64: 752761.
  • 13
    Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H. et al., A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape. J. Immunol. 2002 168: 47724780.
  • 14
    Wiendl, H., Mitsdoerffer, M. and Weller, M., Hide-and-seek in the brain: A role for HLA-G mediating immune privilege for glioma cells. Semin. Cancer Biol. 2003 13: 343351.
  • 15
    Wiendl, H., Behrens, L., Maier, S., Johnson, M. A., Weiss, E. H. and Hohlfeld, R., Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann. Neurol. 2000 48: 679684.
  • 16
    Le Rond, S., Azema, C., Krawice-Radanne, I., Durrbach, A., Guettier, C., Carosella, E. D. and Rouas-Freiss, N., Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J. Immunol. 2006 176: 32663276.
  • 17
    Chumbley, G., King, A., Robertson, K., Holmes, N. and Loke, Y. W., Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell. Immunol. 1994 155: 312322.
  • 18
    Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J. and Carosella, E. D., The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. USA 1997 94: 52495254.
  • 19
    Fournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A. et al., Cutting edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol. 2000 164: 61006104.
  • 20
    Lindaman, A., Dowden, A. and Zavazava, N., Soluble HLA-G molecules induce apoptosis in natural killer cells. Am. J. Reprod. Immunol. 2006 56: 6876.
  • 21
    Fons, P., Chabot, S., Cartwright, J. E., Lenfant, F., L'Faqihi, F., Giustiniani, J., Herault, J. P. et al., Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006 108: 26082615.
  • 22
    Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D. E. and Lopez-Botet, M., The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 1999 29: 277283.
  • 23
    Shiroishi, M., Kuroki, K., Ose, T., Rasubala, L., Shiratori, I., Arase, H., Tsumoto, K. et al., Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 2006 281: 1043910447.
  • 24
    Le Friec, G., Gros, F., Sebti, Y., Guilloux, V., Pangault, C., Fauchet, R. and Amiot, L., Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. J. Leukoc. Biol. 2004 76: 11251133.
  • 25
    Yie, S. M., Li, L. H., Li, Y. M. and Librach, C., HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am. J. Obstet. Gynecol. 2004 191: 525529.
  • 26
    Gros, F., Sebti, Y., de Guibert, S., Branger, B., Bernard, M., Fauchet, R. and Amiot, L., Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006 8: 223230.
  • 27
    Sebti, Y., Le Maux, A., Gros, F., De Guibert, S., Pangault, C., Rouas-Freiss, N., Bernard, M. et al., Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br. J. Haematol. 2007 138: 202212.
  • 28
    Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. et al., Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 2003 100: 88568861.
  • 29
    LeMaoult, J., Krawice-Radanne, I., Dausset, J. and Carosella, E. D., HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc. Natl. Acad. Sci. USA 2004 101: 70647069.
  • 30
    Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S. et al., B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995 2: 523532.
  • 31
    Manzotti, C. N., Liu, M. K., Burke, F., Dussably, L., Zheng, Y. and Sansom, D. M., Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. Eur. J. Immunol. 2006 36: 14131422.
  • 32
    Ristich, V., Liang, S., Zhang, W., Wu, J. and Horuzsko, A., Tolerization of dendritic cells by HLA-G. Eur. J. Immunol. 2005 35: 11331142.
  • 33
    LeMaoult, J., Zafaranloo, K., Le Danff, C. and Carosella, E. D., HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 2005 19: 662664.
  • 34
    Guillard, C., Zidi, I., Marcou, C., Menier, C., Carosella, E. D. and Moreau, P., Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells. Mol. Immunol. 2008 45: 419427
  • 35
    Chuang, S. S., Kumaresan, P. R. and Mathew, P. A., 2B4 (CD244)-mediated activation of cytotocicity and IFN-gamma release in human NK cells involves distinct pathways. J. Immunol. 2001 167: 62106216.
  • 36
    Girart, M. V., Fuertes, M. B., Domaica, C. I., Rossi, L. E. and Zwirner, N. W., Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotocicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 2007 179: 34723479.
  • 37
    Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002 195: 343351.
  • 38
    Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005 106: 566571.
  • 39
    Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B. et al., NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004 104: 32673275.
  • 40
    Vitale, M., Della Chiesa, M., Carlomagno, S., Romagnani, C., Thiel, A., Moretta, L. and Moretta, A., The small subset of CD56brightCD16 natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur. J. Immunol. 2004 34: 17151722.
  • 41
    Lucas, M., Schachterle, W., Oberle, K., Aichele, P. and Diefenbach, A., Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007 26: 503517.
  • 42
    Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002 195: 327333.
  • 43
    Adrian Cabestre, F., Moreau, P., Riteau, B., Ibrahim, E. C., Le Danff, C., Dausset, J., Rouas-Freiss, N. et al., HLA-G expression in human melanoma cells: Protection from NK cytolysis. J. Reprod. Immunol. 1999 43: 183193.